Skip to Content
주식/증권 📈 긍정적

Here's Why You Should Retain Glaukos Stock in Your Portfolio Now

Yahoo Finance 06/05/2026 06:11:00 PM 8회
요약

Glaukos is riding strong on iDose TR growth and launching Epioxa into a large underpenetrated market, but reimbursement and competition risks persist.

원문 기사 보기
관련 뉴스
Trump pledges U.S. aid to Venezuela after deadly twin earthquakes
06/25/2026
Ionis, Recordati inks ex-U.S. license deal for Zilganerse
06/25/2026
Trip.com targets serving 200M inbound travelers over 5 years while expecting Q2 net revenue growth of 3% to 8%
06/25/2026
European markets higher on easing oil prices
06/25/2026
뉴스 목록으로